HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On myocardial siderosis and left ventricular dysfunction in hemochromatosis.

AbstractBACKGROUND:
Chronically increased intestinal iron uptake in genetic hemochromatosis (HC) may cause organ failure. Whilst iron loading from blood transfusions may cause dilated cardiomyopathy in conditions such as thalassemia, the in-vivo prevalence of myocardial siderosis in HC is unclear, and its relation to left ventricular (LV) dysfunction is controversial. Most previous data on myocardial siderosis in HC has come from post-mortem studies.
METHODS:
Cardiovascular magnetic resonance (CMR) was performed at first presentation of 41 HC patients (58.9 ± 14.1 years) to measure myocardial iron and left ventricular (LV) ejection fraction (EF).
RESULTS:
In 31 patients (genetically confirmed HFE-HC), the HFE genotype was C282Y/C282Y (n = 30) and C282Y/H63D (n = 1). Patients with other genotypes (n = 10) were labeled genetically unconfirmed HC. Of the genetically confirmed HFE-HC patients, 6 (19%) had myocardial siderosis (T2* <20 ms). Of these, 5 (83%) had heart failure and reduced LVEF which was correlated to the severity of siderosis (R2 0.57, p = 0.049). Two patients had follow-up scans and both had marked improvements in T2* and LVEF following venesection. Myocardial siderosis was present in 6/18 (33%) of patients with presenting ferritin ≥ 1000 μg/L at diagnosis but in 0/13 (0%) patients with ferritin <1000 μg/L (p = 0.028). Overall however, the relation between myocardial siderosis and ferritin was weak (R2 0.20, p = 0.011). In the 10 genetically unconfirmed HC patients, 1 patient had mild myocardial siderosis but normal EF. Of all 31 patients, 4 had low LVEF from other identifiable causes without myocardial siderosis.
CONCLUSION:
Myocardial siderosis was present in 33% of newly presenting genetically confirmed HFE-HC patients with ferritin >1000 μg/L, and was the commonest cause of reduced LVEF. Heart failure due to myocardial siderosis was only found in these HFE-HC patients, and was reversible with venesection. Myocardial iron was normal in patients with other causes of LV dysfunction.
AuthorsJohn-Paul Carpenter, Agata E Grasso, John B Porter, Farrukh Shah, James Dooley, Dudley J Pennell
JournalJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance (J Cardiovasc Magn Reson) Vol. 15 Pg. 24 (Mar 19 2013) ISSN: 1532-429X [Electronic] England
PMID23509881 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • HFE protein, human
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I
  • Membrane Proteins
  • Ferritins
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Cardiomyopathies (blood, diagnosis, etiology, pathology, physiopathology, therapy)
  • Ferritins (blood)
  • Genetic Predisposition to Disease
  • Heart Failure (blood, etiology, physiopathology)
  • Hemochromatosis (blood, complications, diagnosis, genetics, therapy)
  • Hemochromatosis Protein
  • Hemosiderosis (blood, diagnosis, etiology, pathology, physiopathology, therapy)
  • Histocompatibility Antigens Class I (genetics)
  • Humans
  • Linear Models
  • Magnetic Resonance Imaging
  • Membrane Proteins (genetics)
  • Middle Aged
  • Myocardium (metabolism, pathology)
  • Phenotype
  • Phlebotomy
  • Prospective Studies
  • Stroke Volume
  • Ventricular Dysfunction, Left (blood, diagnosis, etiology, pathology, physiopathology, therapy)
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: